(Q74605816)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9609623%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9609623%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

H Lepor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9609623%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9609623%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9609623%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9609623%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9609623%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

892-900

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9609623%20AND%20SRC:MED&resulttype=core&format=json

Medical therapy for benign prostatic hyperplasia

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900126-5

7 January 2021

A Placebo-controlled Double-blind Study of the Effect of Phenoxybenzamine in Benign Prostatic Obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900126-5

7 January 2021

Bladder Outflow Obstruction Treated with Phenoxybenzamine

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900126-5

7 January 2021

A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic Hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900126-5

7 January 2021

Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: a combined analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900126-5

7 January 2021

Localization of the alpha 1A-adrenoceptor in the human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900126-5

7 January 2021

Prostatic alpha 1-adrenoceptors and uroselectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900126-5

7 January 2021

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900126-5

7 January 2021

Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). The European Tamsulosin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900126-5

7 January 2021

10.1016/S0090-4295(98)00126-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9609623%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference